Overexpression of uridine-cytidine kinase 2 correlates with breast cancer progression and poor prognosis

Guosong Shen, Pingya He, Yingying Mao, Peipei Li, Frank Luh, Guohui Ding, Xiyong Liu, Yun Yen

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Purpose: Uridine-cytidine kinase (UCK) 2 is a rate-limiting enzyme involved in the salvage pathway of pyrimidine-nucleotide biosyn-thesis. Recent studies have shown that UCK2 is overexpressed in many types of cancer and may play a crucial role in activating antitumor prodrugs in human cancer cells. In the current study, we evaluated the potential prognostic value of UCK2 in breast cancer. Methods: We searched public databases to explore associations between UCK2 gene expression and clinical parameters in patients with breast cancer. Gene set enrichment analysis (GSEA) was performed to identify biological pathways associated with UCK2 gene expression levels. Survival analyses were performed using 10 independent large-scale breast cancer microarray datasets. Results: We found that UCK2 mRNA expression was elevated in breast cancer tissue compared with adjacent nontumorous tissue or breast tissue from healthy controls. High UCK2 levels were correlated with estrogen receptor negativity (p<0.001), advanced tumor grade (p<0.001), and poor tumor differentiation (p<0.001). GSEA revealed that UCK2-high breast cancers were enriched for gene sets associated with metastasis, progenitor-like phenotypes, and poor prognosis. Multivariable Cox proportional hazards regression analyses of microarray datasets verified that high UCK2 gene expression was associated with poor overall survival in a dose-response manner. The prognostic power of UCK2 was superior to that of TNM staging and comparable to that of multiple gene signatures. Conclusion: These findings suggest that UCK2 may be a promising prognostic biomarker for patients with breast cancer.

Original languageEnglish
Pages (from-to)132-141
Number of pages10
JournalJournal of Breast Cancer
Volume20
Issue number2
DOIs
Publication statusPublished - Jun 1 2017

Fingerprint

Uridine Kinase
Breast Neoplasms
Gene Expression
Genes
Neoplasms
Pyrimidine Nucleotides
Neoplasm Staging
Prodrugs
Survival Analysis
Estrogen Receptors
Breast
Biomarkers
Regression Analysis
Databases
Neoplasm Metastasis
Phenotype
Messenger RNA
Survival
Enzymes

Keywords

  • Biomarkers
  • Breast neoplasms
  • Prognosis
  • Uridine-cytidine kinase 2

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Cite this

Overexpression of uridine-cytidine kinase 2 correlates with breast cancer progression and poor prognosis. / Shen, Guosong; He, Pingya; Mao, Yingying; Li, Peipei; Luh, Frank; Ding, Guohui; Liu, Xiyong; Yen, Yun.

In: Journal of Breast Cancer, Vol. 20, No. 2, 01.06.2017, p. 132-141.

Research output: Contribution to journalArticle

Shen, Guosong ; He, Pingya ; Mao, Yingying ; Li, Peipei ; Luh, Frank ; Ding, Guohui ; Liu, Xiyong ; Yen, Yun. / Overexpression of uridine-cytidine kinase 2 correlates with breast cancer progression and poor prognosis. In: Journal of Breast Cancer. 2017 ; Vol. 20, No. 2. pp. 132-141.
@article{50c0be7050a7488ab0526dc0d9bb20ea,
title = "Overexpression of uridine-cytidine kinase 2 correlates with breast cancer progression and poor prognosis",
abstract = "Purpose: Uridine-cytidine kinase (UCK) 2 is a rate-limiting enzyme involved in the salvage pathway of pyrimidine-nucleotide biosyn-thesis. Recent studies have shown that UCK2 is overexpressed in many types of cancer and may play a crucial role in activating antitumor prodrugs in human cancer cells. In the current study, we evaluated the potential prognostic value of UCK2 in breast cancer. Methods: We searched public databases to explore associations between UCK2 gene expression and clinical parameters in patients with breast cancer. Gene set enrichment analysis (GSEA) was performed to identify biological pathways associated with UCK2 gene expression levels. Survival analyses were performed using 10 independent large-scale breast cancer microarray datasets. Results: We found that UCK2 mRNA expression was elevated in breast cancer tissue compared with adjacent nontumorous tissue or breast tissue from healthy controls. High UCK2 levels were correlated with estrogen receptor negativity (p<0.001), advanced tumor grade (p<0.001), and poor tumor differentiation (p<0.001). GSEA revealed that UCK2-high breast cancers were enriched for gene sets associated with metastasis, progenitor-like phenotypes, and poor prognosis. Multivariable Cox proportional hazards regression analyses of microarray datasets verified that high UCK2 gene expression was associated with poor overall survival in a dose-response manner. The prognostic power of UCK2 was superior to that of TNM staging and comparable to that of multiple gene signatures. Conclusion: These findings suggest that UCK2 may be a promising prognostic biomarker for patients with breast cancer.",
keywords = "Biomarkers, Breast neoplasms, Prognosis, Uridine-cytidine kinase 2",
author = "Guosong Shen and Pingya He and Yingying Mao and Peipei Li and Frank Luh and Guohui Ding and Xiyong Liu and Yun Yen",
year = "2017",
month = "6",
day = "1",
doi = "10.4048/jbc.2017.20.2.132",
language = "English",
volume = "20",
pages = "132--141",
journal = "Journal of Breast Cancer",
issn = "1738-6756",
publisher = "Korean Breast Cancer Society",
number = "2",

}

TY - JOUR

T1 - Overexpression of uridine-cytidine kinase 2 correlates with breast cancer progression and poor prognosis

AU - Shen, Guosong

AU - He, Pingya

AU - Mao, Yingying

AU - Li, Peipei

AU - Luh, Frank

AU - Ding, Guohui

AU - Liu, Xiyong

AU - Yen, Yun

PY - 2017/6/1

Y1 - 2017/6/1

N2 - Purpose: Uridine-cytidine kinase (UCK) 2 is a rate-limiting enzyme involved in the salvage pathway of pyrimidine-nucleotide biosyn-thesis. Recent studies have shown that UCK2 is overexpressed in many types of cancer and may play a crucial role in activating antitumor prodrugs in human cancer cells. In the current study, we evaluated the potential prognostic value of UCK2 in breast cancer. Methods: We searched public databases to explore associations between UCK2 gene expression and clinical parameters in patients with breast cancer. Gene set enrichment analysis (GSEA) was performed to identify biological pathways associated with UCK2 gene expression levels. Survival analyses were performed using 10 independent large-scale breast cancer microarray datasets. Results: We found that UCK2 mRNA expression was elevated in breast cancer tissue compared with adjacent nontumorous tissue or breast tissue from healthy controls. High UCK2 levels were correlated with estrogen receptor negativity (p<0.001), advanced tumor grade (p<0.001), and poor tumor differentiation (p<0.001). GSEA revealed that UCK2-high breast cancers were enriched for gene sets associated with metastasis, progenitor-like phenotypes, and poor prognosis. Multivariable Cox proportional hazards regression analyses of microarray datasets verified that high UCK2 gene expression was associated with poor overall survival in a dose-response manner. The prognostic power of UCK2 was superior to that of TNM staging and comparable to that of multiple gene signatures. Conclusion: These findings suggest that UCK2 may be a promising prognostic biomarker for patients with breast cancer.

AB - Purpose: Uridine-cytidine kinase (UCK) 2 is a rate-limiting enzyme involved in the salvage pathway of pyrimidine-nucleotide biosyn-thesis. Recent studies have shown that UCK2 is overexpressed in many types of cancer and may play a crucial role in activating antitumor prodrugs in human cancer cells. In the current study, we evaluated the potential prognostic value of UCK2 in breast cancer. Methods: We searched public databases to explore associations between UCK2 gene expression and clinical parameters in patients with breast cancer. Gene set enrichment analysis (GSEA) was performed to identify biological pathways associated with UCK2 gene expression levels. Survival analyses were performed using 10 independent large-scale breast cancer microarray datasets. Results: We found that UCK2 mRNA expression was elevated in breast cancer tissue compared with adjacent nontumorous tissue or breast tissue from healthy controls. High UCK2 levels were correlated with estrogen receptor negativity (p<0.001), advanced tumor grade (p<0.001), and poor tumor differentiation (p<0.001). GSEA revealed that UCK2-high breast cancers were enriched for gene sets associated with metastasis, progenitor-like phenotypes, and poor prognosis. Multivariable Cox proportional hazards regression analyses of microarray datasets verified that high UCK2 gene expression was associated with poor overall survival in a dose-response manner. The prognostic power of UCK2 was superior to that of TNM staging and comparable to that of multiple gene signatures. Conclusion: These findings suggest that UCK2 may be a promising prognostic biomarker for patients with breast cancer.

KW - Biomarkers

KW - Breast neoplasms

KW - Prognosis

KW - Uridine-cytidine kinase 2

UR - http://www.scopus.com/inward/record.url?scp=85022072270&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022072270&partnerID=8YFLogxK

U2 - 10.4048/jbc.2017.20.2.132

DO - 10.4048/jbc.2017.20.2.132

M3 - Article

VL - 20

SP - 132

EP - 141

JO - Journal of Breast Cancer

JF - Journal of Breast Cancer

SN - 1738-6756

IS - 2

ER -